This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed. The above button links to ...

As AI companies warn of the dangers of self-improving AI, a new report offers a rare look at how they’re working to make it a reality.

RXRX is trading in the middle of its 52-week range and near its 200-day simple moving average. Price change The price of RXRX shares has increased $0.02 since the market last closed. This is a 0.57% ...

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

AI is moving at a breakneck pace, and frankly, it’s hard to keep up. Sure, it’s cool to have a chatbot that acts like it has a Ph.D. in everything, but the reality is a lot messier. You can’t turn ...

The Latest: Vision returns alongside Ultron in VisionQuest. The show has been said to be the end of a “Wanda” trilogy that started with WandaVision, and continued with Agatha All Along. See where it ...

The cities with the best quality of life have high scores on U.S. News’ Quality of Life Index. It measures how satisfied residents are with their daily lives, and takes into account factors like crime ...

The last time I spoke about Recursion Pharmaceuticals (RXRX), it was with a Seeking Alpha article entitled "Recursion: "Hold" Rating Based On Initial REC-4881 FAP Treatment Data." With respect to this ...

Salt Lake City, UT, Oct. 15, 2026 (GLOBE NEWSWIRE) -- Recursion Pharmaceuticals, Inc. (“Recursion”) (NASDAQ: RXRX), a leading clinical-stage company pioneering AI-enabled drug discovery and ...

Potential first-in-class dual targeting inhibitor oral small molecule to enter Sanofi’s development pipeline, with phase 1 clinical study currently planned to begin in 2027 Salt Lake City, UT, Oct. 15 ...

Ricursive Intelligence founders Anna Goldie and Azalia Mirhoseini believe more efficient AI chip design could help solve the compute crisis. The founders took the stage at TechCrunch Disrupt on ...